Year |
Citation |
Score |
2023 |
Rok M, Ying Wong TW, Maino E, Ahmed A, Yang G, Hyatt E, Lindsay K, Fatehi S, Marks R, Delgado-Olguín P, Ivakine EA, Cohn RD. Prevention of early-onset cardiomyopathy in exon 52-54 deletion mice by CRISPR-Cas9-mediated exon skipping. Molecular Therapy. Methods & Clinical Development. 30: 246-258. PMID 37545481 DOI: 10.1016/j.omtm.2023.07.004 |
0.367 |
|
2023 |
Fatehi S, Marks RM, Rok MJ, Perillat L, Ivakine EA, Cohn R. Advances in CRISPR/Cas9 Genome Editing for the Treatment of Muscular Dystrophies. Human Gene Therapy. PMID 37119122 DOI: 10.1089/hum.2023.059 |
0.324 |
|
2020 |
Wong TWY, Ahmed A, Yang G, Maino E, Steiman S, Hyatt E, Chan P, Lindsay K, Wong N, Golebiowski D, Schneider J, Delgado-Olguín P, Ivakine EA, Cohn RD. A novel mouse model of Duchenne muscular dystrophy carrying a multi-exonic deletion exhibits progressive muscular dystrophy and early-onset cardiomyopathy. Disease Models & Mechanisms. 13. PMID 32988972 DOI: 10.1242/dmm.045369 |
0.476 |
|
2019 |
Kemaladewi DU, Cohn RD. Development of therapeutic genome engineering in laminin-α2-deficient congenital muscular dystrophy. Emerging Topics in Life Sciences. 3: 11-18. PMID 33523194 DOI: 10.1042/ETLS20180059 |
0.368 |
|
2019 |
Kemaladewi DU, Bassi PS, Erwood S, Al-Basha D, Gawlik KI, Lindsay K, Hyatt E, Kember R, Place KM, Marks RM, Durbeej M, Prescott SA, Ivakine EA, Cohn RD. A mutation-independent approach for muscular dystrophy via upregulation of a modifier gene. Nature. PMID 31341277 DOI: 10.1038/s41586-019-1430-x |
0.463 |
|
2019 |
Kemaladewi DU, Benjamin JS, Hyatt E, Ivakine EA, Cohn RD. Increased polyamines as protective disease modifiers in congenital muscular dystrophy. Human Molecular Genetics. 27: 1905-1912. PMID 29566247 DOI: 10.1093/hmg/ddy097 |
0.594 |
|
2019 |
Kemaladewi DU, Cohn RD. Development of therapeutic genome engineering in laminin-α2-deficient congenital muscular dystrophy Emerging Topics in Life Sciences. 3: 11-18. DOI: 10.1042/ETLS20180059 |
0.368 |
|
2017 |
Wong TWY, Cohn RD. Therapeutic Applications of CRISPR/Cas for Duchenne Muscular Dystrophy. Current Gene Therapy. PMID 29173172 DOI: 10.2174/1566523217666171121165046 |
0.336 |
|
2017 |
Kemaladewi DU, Maino E, Hyatt E, Hou H, Ding M, Place KM, Zhu X, Bassi P, Baghestani Z, Deshwar AG, Merico D, Xiong HY, Frey BJ, Wilson MD, Ivakine EA, ... Cohn RD, et al. Correction of a splicing defect in a mouse model of congenital muscular dystrophy type 1A using a homology-directed-repair-independent mechanism. Nature Medicine. PMID 28714989 DOI: 10.1038/Nm.4367 |
0.361 |
|
2017 |
Zou Y, Donkervoort S, Salo AM, Reghan Foley A, Barnes AM, Hu Y, Makareeva E, Leach ME, Mohassel P, Dastgir J, Deardorff MA, Cohn RD, DiNonno WO, Malfait F, Lek M, et al. P4HA1 mutations cause a unique congenital disorder of connective tissue involving tendon, bone, muscle and the eye. Human Molecular Genetics. PMID 28419360 DOI: 10.1093/Hmg/Ddx110 |
0.438 |
|
2016 |
Cohn RD, Dubowitz V. Duchenne muscular dystrophy: Ringo to the rescue? Neuromuscular Disorders : Nmd. 26: 5-6. PMID 26801251 DOI: 10.1016/j.nmd.2015.12.001 |
0.447 |
|
2016 |
Kemaladewi DU, Cohn RD. Exon Snipping in Duchenne Muscular Dystrophy Trends in Molecular Medicine. 22: 187-189. DOI: 10.1016/j.molmed.2016.01.007 |
0.314 |
|
2015 |
Dubowitz V, Cohn RD. Dystrophin and Duchenne dystrophy. Neuromuscular Disorders : Nmd. 25: 361-2. PMID 25890834 DOI: 10.1016/j.nmd.2015.03.013 |
0.41 |
|
2014 |
Auer DR, Sysa-Shah P, Bedja D, Simmers JL, Pak E, Dutra A, Cohn R, Gabrielson KL, Chakravarti A, Kapoor A. Generation of a cre recombinase-conditional Nos1ap over-expression transgenic mouse. Biotechnology Letters. 36: 1179-85. PMID 24563304 DOI: 10.1007/S10529-014-1473-X |
0.745 |
|
2014 |
MacDonald EM, Andres-Mateos E, Mejias R, Simmers JL, Mi R, Park JS, Ying S, Hoke A, Lee SJ, Cohn RD. Denervation atrophy is independent from Akt and mTOR activation and is not rescued by myostatin inhibition. Disease Models & Mechanisms. 7: 471-81. PMID 24504412 DOI: 10.1242/Dmm.014126 |
0.827 |
|
2014 |
Ivakine EA, Cohn RD. Maintaining skeletal muscle mass: lessons learned from hibernation. Experimental Physiology. 99: 632-7. PMID 24443348 DOI: 10.1113/expphysiol.2013.074344 |
0.638 |
|
2014 |
Chrestian N, Dowling J, Amburgey K, Moraes T, Cohn R, Hawkins C, Halliday W, McAdam L, Biggar D, Vajsar J. G.P.47 Neuromuscular Disorders. 24: 808-809. DOI: 10.1016/J.Nmd.2014.06.061 |
0.391 |
|
2013 |
Xu R, Andres-Mateos E, Mejias R, MacDonald EM, Leinwand LA, Merriman DK, Fink RH, Cohn RD. Hibernating squirrel muscle activates the endurance exercise pathway despite prolonged immobilization. Experimental Neurology. 247: 392-401. PMID 23333568 DOI: 10.1016/J.Expneurol.2013.01.005 |
0.576 |
|
2013 |
Andres-Mateos E, Brinkmeier H, Burks TN, Mejias R, Files DC, Steinberger M, Soleimani A, Marx R, Simmers JL, Lin B, Finanger Hedderick E, Marr TG, Lin BM, Hourdé C, Leinwand LA, ... ... Cohn RD, et al. Activation of serum/glucocorticoid-induced kinase 1 (SGK1) is important to maintain skeletal muscle homeostasis and prevent atrophy. Embo Molecular Medicine. 5: 80-91. PMID 23161797 DOI: 10.1002/Emmm.201201443 |
0.813 |
|
2012 |
Andres-Mateos E, Mejias R, Soleimani A, Lin BM, Burks TN, Marx R, Lin B, Zellars RC, Zhang Y, Huso DL, Marr TG, Leinwand LA, Merriman DK, Cohn RD. Impaired skeletal muscle regeneration in the absence of fibrosis during hibernation in 13-lined ground squirrels. Plos One. 7: e48884. PMID 23155423 DOI: 10.1371/Journal.Pone.0048884 |
0.848 |
|
2012 |
MacDonald EM, Cohn RD. TGFβ signaling: its role in fibrosis formation and myopathies. Current Opinion in Rheumatology. 24: 628-34. PMID 22918531 DOI: 10.1097/BOR.0b013e328358df34 |
0.414 |
|
2012 |
Files DC, D'Alessio FR, Johnston LF, Kesari P, Aggarwal NR, Garibaldi BT, Mock JR, Simmers JL, DeGorordo A, Murdoch J, Willis MS, Patterson C, Tankersley CG, Messi ML, Liu C, ... ... Cohn RD, et al. A critical role for muscle ring finger-1 in acute lung injury-associated skeletal muscle wasting. American Journal of Respiratory and Critical Care Medicine. 185: 825-34. PMID 22312013 DOI: 10.1164/Rccm.201106-1150Oc |
0.843 |
|
2012 |
Burks T, Lucas O, Andres-Mateos E, Marx R, Simmers J, Walston J, Cohn R. T.O.8 Age-dependent effects of angiotensin II blockade on disuse atrophy Neuromuscular Disorders. 22: 908. DOI: 10.1016/J.Nmd.2012.06.345 |
0.812 |
|
2012 |
MacDonald E, Simmers J, Andres-Mateos E, Mejias-Estevez R, Lee S, Cohn R. T.O.6 Myostatin inhibitor ActIIb rescues atrophy and protects muscle growth signaling pathways in immobilization but not denervation Neuromuscular Disorders. 22: 908. DOI: 10.1016/J.Nmd.2012.06.343 |
0.833 |
|
2012 |
Simmers JL, Chaerkady R, Hedderick EF, Marx R, Mejias R, Pandey A, Cohn R. G.P.84 Mislocalization of nNOS alters the interactions between nNOS and proteins involved with muscle contraction in steroid-induced myopathy Neuromuscular Disorders. 22: 837. DOI: 10.1016/J.Nmd.2012.06.118 |
0.834 |
|
2012 |
Cohn RD, Dietz HC. Molecular pathogenesis of skeletal muscle abnormalities in marfan syndrome Muscle. 2: 995-1001. DOI: 10.1016/B978-0-12-381510-1.00071-5 |
0.428 |
|
2011 |
Burks TN, Cohn RD. One size may not fit all: anti-aging therapies and sarcopenia. Aging. 3: 1142-53. PMID 22184279 |
0.834 |
|
2011 |
Abadir PM, Foster DB, Crow M, Cooke CA, Rucker JJ, Jain A, Smith BJ, Burks TN, Cohn RD, Fedarko NS, Carey RM, O'Rourke B, Walston JD. Identification and characterization of a functional mitochondrial angiotensin system. Proceedings of the National Academy of Sciences of the United States of America. 108: 14849-54. PMID 21852574 DOI: 10.1073/Pnas.1101507108 |
0.724 |
|
2011 |
Burks TN, Cohn RD. Role of TGF-β signaling in inherited and acquired myopathies. Skeletal Muscle. 1: 19. PMID 21798096 DOI: 10.1186/2044-5040-1-19 |
0.81 |
|
2011 |
Burks TN, Andres-Mateos E, Marx R, Mejias R, Van Erp C, Simmers JL, Walston JD, Ward CW, Cohn RD. Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia. Science Translational Medicine. 3: 82ra37. PMID 21562229 DOI: 10.1126/Scitranslmed.3002227 |
0.803 |
|
2011 |
Lisi EC, Cohn RD. Genetic evaluation of the pediatric patient with hypotonia: perspective from a hypotonia specialty clinic and review of the literature. Developmental Medicine and Child Neurology. 53: 586-99. PMID 21418198 DOI: 10.1111/j.1469-8749.2011.03918.x |
0.38 |
|
2011 |
Finanger Hedderick EL, Simmers JL, Soleimani A, Andres-Mateos E, Marx R, Files DC, King L, Crawford TO, Corse AM, Cohn RD. Loss of sarcolemmal nNOS is common in acquired and inherited neuromuscular disorders. Neurology. 76: 960-7. PMID 21403107 DOI: 10.1212/Wnl.0B013E31821043C8 |
0.737 |
|
2011 |
Cohn RD. Muscle cramps and coffee Neuromuscular Disorders. 21: 311. PMID 21377365 DOI: 10.1016/j.nmd.2011.02.011 |
0.592 |
|
2010 |
Lee SJ, Lee YS, Zimmers TA, Soleimani A, Matzuk MM, Tsuchida K, Cohn RD, Barton ER. Regulation of muscle mass by follistatin and activins. Molecular Endocrinology (Baltimore, Md.). 24: 1998-2008. PMID 20810712 DOI: 10.1210/me.2010-0127 |
0.628 |
|
2010 |
Burks T, Andres-Mateos E, Simmers J, MacDonald E, van Erp C, Marx R, Cohn R. P3.47 Administration of Losartan improves skeletal muscle repair in mice with sarcopenia Neuromuscular Disorders. 20: 655. DOI: 10.1016/J.Nmd.2010.07.189 |
0.797 |
|
2010 |
Simmers J, Hedderick E, Andres-Mateos E, MacDonald E, Burks T, Marx R, Cohn R. P3.19 Decrease of sarcolemmal nNOS as a molecular marker of muscle atrophy in inherited and acquired forms of myopathy Neuromuscular Disorders. 20: 646-647. DOI: 10.1016/J.Nmd.2010.07.161 |
0.789 |
|
2009 |
Fontana S, Cohn RD. SP-litting the satellite niche to repopulate muscle. Cell Stem Cell. 4: 194-5. PMID 19265654 DOI: 10.1016/J.Stem.2009.02.002 |
0.351 |
|
2007 |
Cohn RD, van Erp C, Habashi JP, Soleimani AA, Klein EC, Lisi MT, Gamradt M, ap Rhys CM, Holm TM, Loeys BL, Ramirez F, Judge DP, Ward CW, Dietz HC. Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. Nature Medicine. 13: 204-10. PMID 17237794 DOI: 10.1038/Nm1536 |
0.397 |
|
2007 |
Cohn RD, van Erp C, Habashi JP, Soleimani AA, Klein EC, Lisi MT, Gamradt M, ap Rhys CM, Holm TM, Loeys BL, Ramirez F, Judge DP, Ward CW, Dietz HC. Erratum: Corrigendum: Angiotensin II type 1 receptor blockade attenuates TGF-β–induced failure of muscle regeneration in multiple myopathic states Nature Medicine. 13: 511-511. DOI: 10.1038/Nm0407-511A |
0.46 |
|
2005 |
Cohn RD. Dystroglycan: important player in skeletal muscle and beyond. Neuromuscular Disorders : Nmd. 15: 207-17. PMID 15725582 DOI: 10.1016/j.nmd.2004.11.005 |
0.349 |
|
2005 |
Cohn RD. Corrigendum to “Dystroglycan: important player in skeletal muscle and beyond” [Neuromuscular Disorders 15 (2005) 207–217] Neuromuscular Disorders. 15: 573. DOI: 10.1016/j.nmd.2005.06.015 |
0.51 |
|
2002 |
Cohn RD, Henry MD, Michele DE, Barresi R, Saito F, Moore SA, Flanagan JD, Skwarchuk MW, Robbins ME, Mendell JR, Williamson RA, Campbell KP. Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration. Cell. 110: 639-48. PMID 12230980 DOI: 10.1016/S0092-8674(02)00907-8 |
0.602 |
|
2002 |
Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, Satz JS, Dollar J, Nishino I, Kelley RI, Somer H, Straub V, Mathews KD, Moore SA, Campbell KP. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature. 418: 417-22. PMID 12140558 DOI: 10.1038/Nature00837 |
0.386 |
|
2001 |
Voit T, Kutz P, Leube B, Neuen-Jacob E, Schröder JM, Cavallotti D, Vaccario ML, Schaper J, Broich P, Cohn R, Baethmann M, Göhlich-Ratmann G, Scoppetta C, Herrmann R. Autosomal dominant distal myopathy: further evidence of a chromosome 14 locus. Neuromuscular Disorders. 11: 11-19. PMID 11166161 DOI: 10.1016/S0960-8966(00)00158-9 |
0.39 |
|
2001 |
Cohn RD, Durbeej M, Moore SA, Coral-Vazquez R, Prouty S, Campbell KP. Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex. The Journal of Clinical Investigation. 107: R1-7. PMID 11160141 DOI: 10.1172/Jci11642 |
0.425 |
|
2000 |
Cohn RD, Campbell KP. Molecular basis of muscular dystrophies. Muscle & Nerve. 23: 1456-71. PMID 11003781 DOI: 10.1002/1097-4598(200010)23:10<1456::Aid-Mus2>3.0.Co;2-T |
0.532 |
|
2000 |
Durbeej M, Cohn RD, Hrstka RF, Moore SA, Allamand V, Davidson BL, Williamson RA, Campbell KP. Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E. Molecular Cell. 5: 141-51. PMID 10678176 DOI: 10.1016/S1097-2765(00)80410-4 |
0.505 |
|
2000 |
Flanigan KM, Kerr L, Bromberg MB, Leonard C, Tsuruda J, Zhang P, Gonzalez-Gomez I, Cohn R, Campbell KP, Leppert M. Congenital muscular dystrophy with rigid spine syndrome: a clinical, pathological, radiological, and genetic study. Annals of Neurology. 47: 152-61. PMID 10665485 DOI: 10.1002/1531-8249(200002)47:2<152::Aid-Ana4>3.0.Co;2-U |
0.46 |
|
1999 |
Coral-Vazquez R, Cohn RD, Moore SA, Hill JA, Weiss RM, Davisson RL, Straub V, Barresi R, Bansal D, Hrstka RF, Williamson R, Campbell KP. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell. 98: 465-74. PMID 10481911 DOI: 10.1016/S0092-8674(00)81975-3 |
0.518 |
|
1999 |
Cohn RD, Mayer U, Saher G, Herrmann R, van der Flier A, Sonnenberg A, Sorokin L, Voit T. Secondary reduction of alpha7B integrin in laminin alpha2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle. Journal of the Neurological Sciences. 163: 140-52. PMID 10371075 DOI: 10.1016/S0022-510X(99)00012-X |
0.367 |
|
1999 |
von Moers A, van Landeghem FK, Cohn RD, Baumgarten E, Bürger J, Stoltenburg-Didinger G. Dystrophinopathy in a boy with Chediak-Higashi syndrome. Neuromuscular Disorders : Nmd. 8: 489-94. PMID 9829279 DOI: 10.1016/S0960-8966(98)00062-5 |
0.4 |
|
Show low-probability matches. |